Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $2.49T
Decision snapshot: LGND stock price vs AMZN: inconclusive — current versus $197.34 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMZN's multiple
Implied fair value · at LGND's multiple
Needs LGND P/E.
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: LGND FY 2025 (ended Dec 31, 2025) · AMZN FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 97% equity / 3% debt · EV / Revenue 3.40x · EV / EBITDA 17.03x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
LIGAND PHARMACEUTICALS INCORPORATED · implied price per share
Bear
$101.45
Base
$119.35
Bull
$137.25
AMAZON COM INC · implied price per share
Bear
$86.41
Base
$101.66
Bull
$116.91
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.25x
0.17x
Net debt / EBITDA
Leverage against operating earnings
-2.31x
-0.36x
Cash and equivalents
Liquid reserves on the balance sheet
$733.52M
$123.03B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Royalty Pharma plc
LGND vs RPRX
Sarepta Therapeutics, Inc.
LGND vs SRPT
INCYTE CORP
LGND vs INCY
EXELIXIS, INC.
LGND vs EXEL
Walmart Inc.
LGND vs WMT
EBAY INC
LGND vs EBAY
MICROSOFT CORP
LGND vs MSFT
Alphabet Inc.
LGND vs GOOGL
Apple Inc.
LGND vs AAPL
TARGET CORP
LGND vs TGT
$252.03M
$71.58B
Live quote
Edwyn research
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Price unavailable
